was read the article
array:21 [ "pii" => "13031954" "issn" => "02126567" "estado" => "S300" "fechaPublicacion" => "2002-04-30" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Aten Primaria. 2002;29:397-406" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3033 "formatos" => array:3 [ "EPUB" => 48 "HTML" => 2660 "PDF" => 325 ] ] "Traduccion" => array:1 [ "es" => array:16 [ "pii" => "13031173" "issn" => "02126567" "estado" => "S300" "fechaPublicacion" => "2002-04-30" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Aten Primaria. 2002;29:397-406" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5250 "formatos" => array:3 [ "EPUB" => 65 "HTML" => 4730 "PDF" => 455 ] ] "es" => array:11 [ "idiomaDefecto" => true "titulo" => "Evaluación, mejora y monitorización de la prescripción de medicamentos genéricos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "397" "paginaFinal" => "406" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Evaluating, improving and monitoring generic drug prescription" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J J López-Picazo Ferrer, JA Sanz Moreno, JM Bernal Montañés, JF Sánchez Ruiz" "autores" => array:4 [ 0 => array:2 [ "Iniciales" => "J J" "apellidos" => "López-Picazo Ferrer" ] 1 => array:2 [ "Iniciales" => "JA" "apellidos" => "Sanz Moreno" ] 2 => array:2 [ "Iniciales" => "JM" "apellidos" => "Bernal Montañés" ] 3 => array:2 [ "Iniciales" => "JF" "apellidos" => "Sánchez Ruiz" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:8 [ "pii" => "13031954" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031954?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031173?idApp=UINPBA00004N" "url" => "/02126567/0000002900000007/v0_201607121052/13031173/v0_201607121052/es/main.assets" ] ] "itemSiguiente" => array:16 [ "pii" => "13031173" "issn" => "02126567" "estado" => "S300" "fechaPublicacion" => "2002-04-30" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Aten Primaria. 2002;29:397-406" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5250 "formatos" => array:3 [ "EPUB" => 65 "HTML" => 4730 "PDF" => 455 ] ] "es" => array:11 [ "idiomaDefecto" => true "titulo" => "Evaluación, mejora y monitorización de la prescripción de medicamentos genéricos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "397" "paginaFinal" => "406" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Evaluating, improving and monitoring generic drug prescription" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J J López-Picazo Ferrer, JA Sanz Moreno, JM Bernal Montañés, JF Sánchez Ruiz" "autores" => array:4 [ 0 => array:2 [ "Iniciales" => "J J" "apellidos" => "López-Picazo Ferrer" ] 1 => array:2 [ "Iniciales" => "JA" "apellidos" => "Sanz Moreno" ] 2 => array:2 [ "Iniciales" => "JM" "apellidos" => "Bernal Montañés" ] 3 => array:2 [ "Iniciales" => "JF" "apellidos" => "Sánchez Ruiz" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:8 [ "pii" => "13031954" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031954?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031173?idApp=UINPBA00004N" "url" => "/02126567/0000002900000007/v0_201607121052/13031173/v0_201607121052/es/main.assets" ] "itemAnterior" => array:15 [ "pii" => "13031171" "issn" => "02126567" "estado" => "S300" "fechaPublicacion" => "2002-04-30" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Aten Primaria. 2002;29:395-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2529 "formatos" => array:3 [ "EPUB" => 48 "HTML" => 2164 "PDF" => 317 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "A propósito del Día Mundial del Asma" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "395" "paginaFinal" => "396" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Concerning World Asthma Day" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "K Naberan Toña" "autores" => array:1 [ 0 => array:2 [ "Iniciales" => "K" "apellidos" => "Naberan Toña" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031171?idApp=UINPBA00004N" "url" => "/02126567/0000002900000007/v0_201607121052/13031171/v0_201607121052/es/main.assets" ] "asociados" => array:1 [ 0 => array:16 [ "pii" => "13031955" "issn" => "02126567" "estado" => "S300" "fechaPublicacion" => "2002-04-30" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Aten Primaria. 2002;29:406" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1966 "formatos" => array:3 [ "EPUB" => 53 "HTML" => 1568 "PDF" => 345 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Commentary: Opportunities to improve generic drug prescribing" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "406" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M Ausejo Segura" "autores" => array:1 [ 0 => array:2 [ "Iniciales" => "M" "apellidos" => "Ausejo Segura" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:8 [ "pii" => "13031175" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031175?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031955?idApp=UINPBA00004N" "url" => "/02126567/0000002900000007/v0_201607121052/13031955/v0_201607121052/en/main.assets" ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Evaluating, improving and monitoring generic drug prescription" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "397" "paginaFinal" => "406" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "JJ López-Picazo Ferrer, JA Sanz Moreno, JM Bernal Montañés, JF Sánchez Ruiz" "autores" => array:4 [ 0 => array:3 [ "Iniciales" => "JJ" "apellidos" => "López-Picazo Ferrer" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "Iniciales" => "JA" "apellidos" => "Sanz Moreno" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "Iniciales" => "JM" "apellidos" => "Bernal Montañés" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] 3 => array:3 [ "Iniciales" => "JF" "apellidos" => "Sánchez Ruiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Physician, Family Medicine Specialist. Quality, Pharmacy and Informatics Unit, Gerencia de Atención Primaria, Instituto Nacional de Salud (INSALUD), Murcia, Spain" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Pharmacist, Hospital Pharmaceutics Specialist. Quality, Pharmacy and Informatics Unit, Gerencia de Atención Primaria, Instituto Nacional de Salud (INSALUD), Murcia, Spain" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 2 => array:3 [ "entidad" => "D. Pharm, Hospital Pharmaceutics Specialist. Quality, Pharmacy and Informatics Unit, Gerencia de Atención Primaria, Instituto Nacional de Salud (INSALUD), Murcia, Spain" "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] 3 => array:3 [ "entidad" => "Informatics Engineer, Associate Professor, University of Murcia, Murcia, Spain." "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "textoCompleto" => "<p class="elsevierStylePara">Introduction</p><hr></hr><p class="elsevierStylePara">Drug prescription, a decision-making process that physicians must often perform,<span class="elsevierStyleSup">1</span> is one of the largest items of health resource consumption in the Spanish National Health System.<span class="elsevierStyleSup">2</span> The analysis of prescribing practices--which vary widely--is not a simple task,<span class="elsevierStyleSup">3,4</span> as it involves issues of effectiveness and efficiency, as well as consideration of the patients´ needs and expectations.<span class="elsevierStyleSup">5</span></p><p class="elsevierStylePara">According to the World Health Organization, the continuous evaluation of prescribing behavior should be customary practice to guarantee the quality of treatment and control iatrogenic risks.<span class="elsevierStyleSup">6</span> In addition, the use of drugs satisfies all three characteristics that have been suggested for measures that require evaluation and monitoring (high frequency, high risk and tendency to create problems).<span class="elsevierStyleSup">7</span> Monitoring of drug use can be approached from three standpoints, which Saturno<span class="elsevierStyleSup">8</span> has called pharmacologic (efficacy and effectiveness of drugs), economic (efficiency and optimization of use) and structural rationality. This systematic analysis has become a necessity in efforts to improve drug use.<span class="elsevierStyleSup">9</span></p><p class="elsevierStylePara">However, this approach (measuring what is done accompanied by interventions to do it better) is not the most widely known one. In Spain the health system provides mainly quantitative information aimed at controlling costs,<span class="elsevierStyleSup">10</span> although information from a qualitative viewpoint is becoming more commonplace<span class="elsevierStyleSup">11,12</span> (possibly because of an awareness that better prescribing practices lead, in the long run, to cost savings).<span class="elsevierStyleSup">13</span> However, qualitative information seems at present to be insufficient in itself to improve practices. As a result the World Organization of family doctors developed five steps to be followed to attain and maintain improvements in the use of medications.<span class="elsevierStyleSup">14</span></p><p class="elsevierStylePara">The present study reports the results of a specially-designed intervention to evaluate and improve the prescribing behavior of family physicians (FP) in a regional primary care district in Spain.</p><hr></hr><p class="elsevierStylePara">Material and methods</p><hr></hr><p class="elsevierStylePara">The regional primary care district of Murcia comprises four of the six health areas in the autonomous region of Murcia, in southeastern Spain. In 1998, when the study was begun, it employed 339 FP organized in 45 primary care teams, who provided medical care to 670 287 inhabitants.</p><p class="elsevierStylePara">Choice of indicator</p><p class="elsevierStylePara">Data on the prescriptions dispensed in the regional primary care district were obtained from the monthly reports of prescriptions sent to the Official College of Pharmacists. These lists detailed the medications prescribed by each FP that are covered by the national health system and which were dispensed through pharmacies, but did not identify the patients for whom the medications were prescribed. Of all potential indicators, we chose the percent proportion of prescriptions for generic drugs relative to the total number of prescriptions dispensed during a given month, for those medications that had a generic alternative (percentage of generic prescriptions, PGP). We defined generic drug to mean a medication marketed under its international nonproprietary name and the name of the manufacturer, which had documented therapeutic equivalence to the reference (brand name) medication, and which cost less than the reference medication. In Spain generic drugs are designated EFG <span class="elsevierStyleItalic"> (especialidad farmacéutica genérica).</span><span class="elsevierStyleSup">15</span></p><p class="elsevierStylePara">Implementation of the intervention</p><p class="elsevierStylePara">From October 1998 to March 2000 the office of management of the regional primary care district ran a program aimed at facilitating improvements in drug prescribing practices. The program consisted of the following actions:</p><p class="elsevierStylePara"><span class="elsevierStyleItalic">1.</span> Each FP received an individual monthly report of his or her prescribing practices, in which changes in PGP over time since January 1998 were graphed. Information about the changes in PGP for the physician´s primary care team and for the entire primary health care district over the same period was also provided. Physicians and pharmacies were still required to submit monthly reports of prescriptions and pharmaceutical costs.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic">2.</span> Each semester all FP received a personal letter and a specially-printed card listing the generic drugs available and their pharmaceutical forms, grouped according to indication (anti-infectives, neuropsychiatric drugs, cardiovascular drugs, digestive system drugs, analgesics, anti-inflammatories, miscellaneous) and arranged in alphabetical order. The cards were updated every six months to include new generics on the market, which were highlighted. Each card was sent together with a personal letter from the head of the office of management to all FP in the regional primary care district and to all physicians under temporary contract with the regional public health system. The cards were designed to be esthetically pleasing, and were printed on heavy, durable stock, then laminated. Different groups of drugs were highlighted with different colors. The cards were sized (165 x 100 mm) to fit inside the breast pocket of a lab coat or to be affixed to the computerized prescription label printer.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic">3.</span> One to three (mode, two) face-to-face clinical outreach sessions were held with each primary care team. These meetings were called by the team member responsible for quality control, and were held during working hours. During these meetings, members of the primary care team discussed the most recent report on generic drug prescribing behavior and the best generics available as alternatives to brand-name medications.</p><p class="elsevierStylePara"><span class="elsevierStyleItalic">4.</span> Specific prescribing goals for the PGP were set for the years 1999 (12.0%) and 2000 (20.0%), and incentives to attain the goals were included in the terms of the contract for clinical services signed between the office of management of the regional primary care district and each primary care team. These contracts were signed by each FP on the primary care team, and a salary bonus of 250 000 pesetas (about 1500 euros) per practitioner was stipulated if the goals were met. The final amount of the payment for each primary care team was determined by the specific goals met with regard to (in addition to the PGP) the results for services provided, remaining within budgetary allowances for staff substitutions, drug costs, accessibility and waiting periods, and user satisfaction surveys. Payments were distributed among members of the primary care team who signed the clinical services contract on the basis of agreed-upon criteria which were ratified by the office of management.</p><p class="elsevierStylePara">Evaluation of effectiveness</p><p class="elsevierStylePara">The effectiveness of the program was evaluated in two ways. Improvements in prescribing behavior were tracked by calculating the absolute and relative differences in PGP between the 3-month period immediately preceding the program (July to September 1998) and the 3 months immediately after the program (January to March 2000). To calculate relative improvement, absolute improvement was divided by total potential improvement.</p><p class="elsevierStylePara">In addition, we monitored PGP with statistical quality control methods.<span class="elsevierStyleSup">16</span> Essentially, variability of the indicator was graphed to judge whether the indicator showed stable behavior; this analysis was done with methods similar to those traditionally used to compare hypotheses. According to the null hypothesis the indicator would remain stable. The alternative hypothesis--that the indicator would show variability--was confirmed by visual analysis of the shape of the curve. We monitored PGP with control charts.<span class="elsevierStyleSup">17</span> Changes in PGP about an average value were plotted with limits at ± 3 standard deviations (SD), which represented a risk of * error <0.01. We also defined three zones above and below the average (A, B and C), delimited by ±1, ±2 and ±3 SD, to facilitate the visualization of patterns of distribution of the indicator that might suggest variability, and to increase the sensitivity of the graph. The distribution patterns were based on those described by Kume<span class="elsevierStyleSup">17</span> and Farnum<span class="elsevierStyleSup">18</span> as adapted by Saturno.<span class="elsevierStyleSup">16</span> The same technique was used to check stability of the indicator before and after the intervention. For the pre-intervention analysis we used PGP values for the period from January to September 1998, and for the post-intervention analysis the values were those for the period from January 2000 to March 2001.</p><p class="elsevierStylePara"><img src="27v29n07-13031954tab01.gif"></img></p><p class="elsevierStylePara">Results</p><hr></hr><p class="elsevierStylePara">Prescribing practices for all FP in the Murcia regional primary care district were analyzed. A total of 24 466 872 packages of medications were dispensed, for a mean of 827 816 packages per month (maximum 1 035 132, minimum 668 042, SD 86 904).</p><p class="elsevierStylePara">The pre-intervention PGP was 2.79%, and the post-intervention figure was 17.63%. Absolute improvement was therefore 14.84%, and relative improvement was 15.27%. Monthly PGP values ranged from 1.77% to 27.97%, with a mean of 13.08% and an SD of 7.54%. In the pre-intervention period (before October 1998) mean PGP was 3.12%. During the intervention (October 1998 to December 1999), mean PGP was 11.90%, and after the intervention (January 2000 to March 2001), mean PGP was 20.25%. Table 1 shows the changes in PGP and in the number of packages of drugs prescribed in each phase. The control charts for each phase are shown in Figures 1 to 3. We saw no signs of significant variability in the pre- and post-intervention phases based on the criteria used in this study. In the intervention phase we noted a sequence indicating significant variability, which consisted of five successively increasing values from June 1999 onward.</p><p class="elsevierStylePara"><img src="27v29n07-13031954tab02.gif"></img></p><p class="elsevierStylePara">Discussion</p><hr></hr><p class="elsevierStylePara">The choice of indicator</p><p class="elsevierStylePara">The development and choice of indicators is an activity that is basic to monitoring and quality assurance programs.<span class="elsevierStyleSup">19</span> The indicators used to measure drug prescribing or dispensation should show adequate validity and reliability, and should also be specifically focused.<span class="elsevierStyleSup">20</span> In this regard, indicators developed from user reports appear to represent one of the best choices,<span class="elsevierStyleSup">21</span> as they have been shown to have appropriate levels of validity<span class="elsevierStyleSup">22,23</span> and to provide information that cannot be obtained from any other source,<span class="elsevierStyleSup">24</span> because they shift the center of attention from the drug<span class="elsevierStyleSup">25</span> to the patient, which then becomes the preferential unit of study.<span class="elsevierStyleSup">26,27</span></p><p class="elsevierStylePara">However, the factor most often used to decide which indicator to use has traditionally been availability of the data and ease in obtaining them.<span class="elsevierStyleSup">8</span> This approach, which we used here in the form of the monthly reports of packages of drugs sold through the pharmacies, may appear less than ideal as it provides indicators whose focus is global or related with efficiency.<span class="elsevierStyleSup">10</span> Nonetheless, a high rate of generic prescribing has been related with improvements in drug use,<span class="elsevierStyleSup">8</span> and many examples of this association have been published.<span class="elsevierStyleSup">28-32</span> There is also a recognized relationship between generic prescribing and improvements in efficiency,<span class="elsevierStyleSup">33,34</span> one of the quality dimensions recognized by most authors. Because of its validity and because of the accessibility of the data, we decided to use generic drug prescribing as an indicator to evaluate, enhance and monitor drug use, although we were aware of the existence of other features of prescribing behavior not considered here but known to be involved in the rational use of drugs.</p><p class="elsevierStylePara">The choice of the PGP indicator proposed by the Spanish National Institute of Health (INSALUD) on in its program for improving prescription practices,<span class="elsevierStyleSup">11</span> as opposed to other indicators traditionally used in studies of generic prescribing<span class="elsevierStyleSup">26-32</span> (absolute percentage of generic drugs prescribed, prescriptions adjusted for population, daily doses per 1000 inhabitants, choice of active principles, cost savings, ect.), was motivated by the rapid appearance of new products and active principles in the form of generics during the study period. An indicator unable to take these new products into account might have shown an artificial tendency toward improved prescribing practices by greatly increasing the number of prescriptions for which a generic alternative was available.</p><p class="elsevierStylePara">The intervention</p><p class="elsevierStylePara">The measures that can be taken to improve drug utilization are many and varied. They appear to be more effective when accompanied by quality control methods, when they are preferentially internal in nature, and when they are implemented in small groups, ideally in face-to-face meetings.<span class="elsevierStyleSup">35,36</span> According to some authors, measures aimed at training are the most useful;<span class="elsevierStyleSup">37</span> however, such interventions cannot be used limitlessly, as studies have shown that such measures lose their effectiveness if they are used more than two or three times a year.<span class="elsevierStyleSup">38</span> Educational measures that emphasize information about prescribing practices have also been shown effective,<span class="elsevierStyleSup">39,40</span> and their effectiveness is maintained with time.<span class="elsevierStyleSup">41</span> Effectiveness is influenced to a great extent by the type of indicators contained in the available information. For example, those that monitor features of prescribing-on which there is no clear consensus among FPs-or those that simply reflect prescribing patterns,<span class="elsevierStyleSup">42</span> do not seem able to significantly improve prescribing quality. The use of generics, ie, the indicator we chose in the present study, is not among this group of indicators, and has been found useful on other occasions.<span class="elsevierStyleSup">28,39</span></p><p class="elsevierStylePara">Our intervention was intended to include characteristics that have been shown to be associated with greater effectiveness. The most important of these features are: <span class="elsevierStyleItalic">a)</span> personalized information about prescribing behavior and proposals to improve prescribing rates (pocket card listing generic drugs); <span class="elsevierStyleItalic">b)</span> control charts and graphically-presented information used to make information more attractive and readily assimilated by FPs; <span class="elsevierStyleItalic">c)</span> face-to-face sessions with FPs to take advantage of positive peer pressure in favor of changing prescribing habits; <span class="elsevierStyleItalic"> d)</span> information provided twice yearly on how to attain further improvements, supplied on pocket cards; <span class="elsevierStyleItalic">e)</span> use of specific goals to be reached, identifiable with the desired quality standard, and <span class="elsevierStyleItalic">f)</span> involving FPs in the design of incentives, which required explicit commitments from the practitioners.</p><p class="elsevierStylePara">Proven effectiveness</p><p class="elsevierStylePara">The results we obtained reflected an increase in generic prescribing both in percentage terms and as seen in the control charts (Table 1). Because we used complete records of prescriptions dispensed through the pharmacies to calculate PGP (ie, the figures reflected prescriptions actually dispensed, not estimates, for the entire regional primary care district ), it was not necessary to use tests of statistical significance to document improvements. On the other hand, statistical quality control techniques showed that the indicator was stable before and after the intervention (Figures 1 and 3) and varied significantly toward improvement during the intervention (Figure 2). This is evidence that the program we designed was responsible for the improvements.</p><p class="elsevierStylePara"><img src="27v29n07-13031954tab03.gif"></img></p><p class="elsevierStylePara"><img src="27v29n07-13031954tab04.gif"></img></p><p class="elsevierStylePara"><img src="27v29n07-13031954tab05.gif"></img></p><p class="elsevierStylePara">We should note that the INSALUD reported an overall increase in the use of generics for the period when our study was carried out.<span class="elsevierStyleSup">10</span> This situation was expected in the light of the increasing number of generic drugs on the market in Spain. However, the use of raw percentages of prescriptions in the INSALUD reports means that these improvements may represent «false positives» induced by the increased availability of generics. We tried to avoid this pitfall by using the PGP, which «standardizes» the actual number of prescriptions against the number of generic drugs available.</p><p class="elsevierStylePara">It should be recalled, however, that this study centered on evaluating and improving prescription behavior, and was not designed explicitly to evaluate the effectiveness of our intervention. The evidence we provide is therefore insufficient to state that the improvement observed was a direct consequence of our program. Such proof will require further studies designed to compare the present results with those obtained in a control group; no such group was used here, as we included in our program all FPs in the regional primary care district under study. As in the present report, many other earlier studies also lacked a control group, and as several authors have noted,<span class="elsevierStyleSup">28,43</span> the effectiveness of the interventions they studied should be interpreted with caution.</p><p class="elsevierStylePara">The statistical control techniques we used were shown to be useful, and would appear to be indispensable for the efficient monitoring of change in prescribing practices. These techniques make it possible to promptly detect opportunities for improvement (unfavorable trends) and take appropriate measures.</p><p class="elsevierStylePara"><img src="27v29n07-13031954tab06.gif"></img></p><p class="elsevierStylePara">Acknowledgments</p><hr></hr><p class="elsevierStylePara">The present study was made possible thanks to the teachings and advice of Dr. Pedro J. Saturno of the Preventive Medicine Teaching Unit at the University of Murcia. The training and support provided through the EMCA program of the Health Council of the Region of Murcia were also fundamental for the performance of this study.</p><p class="elsevierStylePara"> </p>" "pdfFichero" => "27v29n07a13031954pdf001.pdf" "tienePdf" => true "tieneResumen" => true "resumen" => array:1 [ "en" => array:1 [ "resumen" => "Objective. To evaluate and improve generic drug prescription by family physicians in a regional primary care district with a specially-designed intervention. Design. Uncontrolled study of an intervention, based quality evaluation and improvement methods. We selected an indicator that could be constructed with the available data (monthly reports of prescriptions dispensed through the public national health system) and determined the proportion of prescriptions for generic drugs to the total number of prescriptions dispensed, for those medications that had a generic alternative (percentage of generic prescriptions, PGP). After these data were evaluated, an intervention was implemented to increase generic prescriptions. Prescribing behavior was again evaluated and monitored at the end of the intervention period. Setting. Forty-five primary care teams in the Murcia (Southeast Spain) regional primary care district. Participants. A total of 339 family physicians. Interventions. During 15 months, individual reports of prescribing practices, in which changes over time were graphed, were sent to each participating prescriber. Each semester the physicians received a personal letter and a specially-printed, updated card showing the generic medications available and their pharmaceutical forms. One to three face-to-face clinical outreach sessions were held with each primary care team. Specific prescribing goals for the PGP were set and incentives to attain the goals were included in the terms of the contract for clinical services signed between the regional office of primary care management and each primary care team. Main outcome measures. The PGP increased from a pre-intervention rate of 2.7% to a post-intervention rate of 17.63%. Absolute improvement was therefore 14.84%, and relative improvement was 15.27%. Variability was monitored and analyzed with control charts. There was no significant variability within the pre- and post-intervention phases, whereas variability increased significantly (indicating improvement) during the intervention phase. Conclusions. The increase in PGP showed that prescribing for generic preparations improved. Statistical quality control tests were useful in evaluating and tracking the results of the intervention, and were indispensable for monitoring and promptly detecting opportunities to improve prescribing behavior and take appropriate measures." ] ] "multimedia" => array:12 [ 0 => array:6 [ "identificador" => "tbl1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "27v29n07-13031954tab01.gif" "imagenAlto" => 802 "imagenAncho" => 366 "imagenTamanyo" => 21004 ] ] ] ] ] ] 1 => array:6 [ "identificador" => "tbl2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "27v29n07-13031954tab02.gif" "imagenAlto" => 925 "imagenAncho" => 765 "imagenTamanyo" => 26254 ] ] ] ] ] ] 2 => array:6 [ "identificador" => "tbl3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "27v29n07-13031954tab03.gif" "imagenAlto" => 386 "imagenAncho" => 730 "imagenTamanyo" => 26783 ] ] ] ] ] ] 3 => array:6 [ "identificador" => "tbl4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "27v29n07-13031954tab04.gif" "imagenAlto" => 422 "imagenAncho" => 730 "imagenTamanyo" => 30749 ] ] ] ] ] ] 4 => array:6 [ "identificador" => "tbl5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "27v29n07-13031954tab05.gif" "imagenAlto" => 356 "imagenAncho" => 730 "imagenTamanyo" => 31570 ] ] ] ] ] ] 5 => array:6 [ "identificador" => "tbl6" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "27v29n07-13031954tab06.gif" "imagenAlto" => 626 "imagenAncho" => 366 "imagenTamanyo" => 27888 ] ] ] ] ] ] 6 => array:5 [ "identificador" => "tbl7" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] 7 => array:5 [ "identificador" => "tbl8" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] 8 => array:5 [ "identificador" => "tbl9" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] 9 => array:5 [ "identificador" => "tbl10" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] 10 => array:5 [ "identificador" => "tbl11" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] 11 => array:5 [ "identificador" => "tbl12" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:43 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "General practitioners for rational use of drugs. Examples from Sweden. Eur J Clin Pharmacol 1994;47:213-9." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "General practitioners for rational use of drugs. Examples from Sweden." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Tomson Y" 1 => "Wessling A" 2 => "Tomson G." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Pharmacol" "fecha" => "1994" "volumen" => "47" "paginaInicial" => "213" "paginaFinal" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7867673" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Sucinta descripción del sistema y evaluación del mismo. Apéndice de la Comisión. Madrid, 1991." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Comisión de Análisis y Evaluación del Sistema Nacional de Salud." ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "The analysis of prescribing in general practice. A guide to audit and research. London: HMSO, 1990." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Harris CM" 1 => "Heywood PL" 2 => "Clayden AD." ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Prescribing in Europe: forces for change. BMJ 1992;304:239-42." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Prescribing in Europe: forces for change." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Taylor D." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1992" "volumen" => "304" "paginaInicial" => "239" "paginaFinal" => "42" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1739801" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Factores que influyen en la selección de medicamentos por el médico de atención primaria. Aten Primaria 1997;20(Supl 1):76-80." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Factores que influyen en la selección de medicamentos por el médico de atención primaria." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Baos V." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Aten Primaria" "fecha" => "1997" "volumen" => "20" "paginaInicial" => "76" "paginaFinal" => "80" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Euro reports and studies 91. Drugs in general practice. Geneva: WHO, 1982." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "WHO." ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Quality assurance in ambulatory care. 2nd ed. Chapter 4. Chicago: JCAHO, 1990." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Joint Commission on Accreditation of Healthcare Organizations." ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Monitorización del uso de medicamentos para mejorar la calidad de prescripción. Problemas, métodos e indicadores. Aten Primaria 1996;18:331-8." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Monitorización del uso de medicamentos para mejorar la calidad de prescripción. Problemas, métodos e indicadores." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Saturno PJ." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1996" "volumen" => "18" "paginaInicial" => "331" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8983390" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "What constitutes good prescription? BMJ 1995;310: 923-5." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "What constitutes good prescription?" "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Barber N." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1995" "volumen" => "310" "paginaInicial" => "923" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7719188" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Indicadores de calidad de prescripción. Madrid: INSALUD, 1993." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "INSALUD." ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Programa de mejora de la prescripción farmacológica en atención primaria. Madrid: INSALUD, 1998." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "INSALUD." ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Informe sobre indicadores cualitativos de la prescripción de medicamentos. Subdirección General de Prestaciones y Evaluación de Tecnologías Sanitarias. Madrid: Ministerio de Sanidad y Consumo, 1994." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Del Río A" 1 => "Guerra L." ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Changing to generic formulary: how one fundholding practice reduced prescribing costs. BMJ 1995;310:505-8." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Changing to generic formulary: how one fundholding practice reduced prescribing costs." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Dowell JS" 1 => "Snadden D" 2 => "Dunbar JA." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1995" "volumen" => "310" "paginaInicial" => "505" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7677830" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Quality assurance for family doctors. Report of the Quality Assurance Working Party. World Organization of Family Doctors. WONCA: Wellington, 1992." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Marwick J" 1 => "Grol R" 2 => "Borgiel A." ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Ley 13/96 de 30 de diciembre, de Medidas Fiscales, Administrativas y del Orden Social. Artículo 169, de modificación de la Ley del Medicamento, 25/1990." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Boletín Oficial del Estado." ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Control estadístico de la calidad. Monitorización con gráficos de control. En: Tratado de calidad asistencial en atención primaria. Vol. II. Madrid: Dupont Pharma, 1997; p.307-44." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Saturno PJ." ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Gráficas de control. En: Herramientas estadísticas básicas para el mejoramiento de la calidad. Bogotá: Norma, 1992; p. 101-51." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Kume H." ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Control chart concepts. En: Modern statistical quality control and improvement. Belmont: Duxburg Press, 1994." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Farnum NR." ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Characteristics of clinical indicators. QRB 1989;nov.:330-9." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Joint Commission on Accreditation of Healthcare Organizations." ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Validez de la utilidad terapéutica y el valor intrínseco como indicadores de calidad de la prescripción farmacéutica: análisis de los tratamientos en casos de resfriado común. Aten Primaria 1997;19:400-6." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Validez de la utilidad terapéutica y el valor intrínseco como indicadores de calidad de la prescripción farmacéutica: análisis de los tratamientos en casos de resfriado común." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Saturno PJ" 1 => "Gascón JJ." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1997" "volumen" => "19" "paginaInicial" => "400" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9254151" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "El informe del usuario como herramienta para la evaluación y mejora de la calidad de prescripción de medicamentos. Murcia: Universidad de Murcia, 1999." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "López-Picazo Ferrer JJ." ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Patients´ perceptions of office medical practice: judging quality through the patients´ eyes. Am J Med Qual 1996;11:73-80." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Patients´ perceptions of office medical practice: judging quality through the patients´ eyes." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Epstein KR" 1 => "Laine C" 2 => "Farber NJ" 3 => "Nelson EC" 4 => "Davidoff F." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Med Qual" "fecha" => "1996" "volumen" => "11" "paginaInicial" => "73" "paginaFinal" => "80" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8704500" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Utilidad del informe del usuario en la monitorización del uso racional de medicamentos. Aten Primaria 2001;27:395-402." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Utilidad del informe del usuario en la monitorización del uso racional de medicamentos." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Gascón JJ" 1 => "Saturno PJ" 2 => "Sánchez JA y Grupo de Trabajo del Proyecto PROSPER." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "2001" "volumen" => "27" "paginaInicial" => "395" "paginaFinal" => "402" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11334576" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Medición de la calidad de prescripción de medicamentos a través de informes de usuario. XVII Congreso de la SECA. Rev Calidad Asistencial 1999;14:455." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Medición de la calidad de prescripción de medicamentos a través de informes de usuario. XVII Congreso de la SECA." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "López-Picazo JJ" 1 => "Saturno PJ" 2 => "Gascón JJ." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Rev Calidad Asistencial" "fecha" => "1999" "volumen" => "14" "paginaInicial" => "455" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Opportunities and responsibilities in pharmaceutical care." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Hepler CD" 1 => "Strand LM." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Hosp Pharm" "fecha" => "1990" "volumen" => "47" "paginaInicial" => "533" "paginaFinal" => "43" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2316538" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Screening for prescribing errors. Am Pharma 1991;31:71-9." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Screening for prescribing errors." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Rupp MT." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am Pharma" "fecha" => "1991" "volumen" => "31" "paginaInicial" => "71" "paginaFinal" => "9" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The role of patient interventions in ambulatory quality assurance programs. Health Educ Q 1982;9:42-54." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The role of patient interventions in ambulatory quality assurance programs." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Wilner S" 1 => "Winickoff RN" 2 => "Schoenbaum SC" 3 => "Coltin KL." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Health Educ Q" "fecha" => "1982" "volumen" => "9" "paginaInicial" => "42" "paginaFinal" => "54" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7152969" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Impacto de una estrategia de intervención en la prescripción de genéricos en un área de atención primaria. Aten Primaria 1999;23:419-24." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Impacto de una estrategia de intervención en la prescripción de genéricos en un área de atención primaria." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Calvo MJ" 1 => "Iñesta A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1999" "volumen" => "23" "paginaInicial" => "419" "paginaFinal" => "24" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10363394" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Consumo de especialidades con denominación genérica en el Área I de la Comunidad Autónoma de Aragón. Aten Primaria 1999;23:301-5." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Consumo de especialidades con denominación genérica en el Área I de la Comunidad Autónoma de Aragón." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Camarena Y" 1 => "Sicilia A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1999" "volumen" => "23" "paginaInicial" => "301" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10341463" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Prescripción de genéricos. Aten Primaria 1994;13:223-4." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Prescripción de genéricos." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Guerra FJ" 1 => "Crespo B." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1994" "volumen" => "13" "paginaInicial" => "223" "paginaFinal" => "4" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7654918" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib31" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Prescripción de genéricos en Área de Salud de Zamora. Beneficios para el usuario y el Sistema Nacional de Salud. Aten Primaria 1997;20:499-504." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Prescripción de genéricos en Área de Salud de Zamora. Beneficios para el usuario y el Sistema Nacional de Salud." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Díaz A" 1 => "López A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1997" "volumen" => "20" "paginaInicial" => "499" "paginaFinal" => "504" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9477634" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib32" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Medicamentos genéricos en España: primera etapa. Aten Primaria 2000;26:66-76." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Medicamentos genéricos en España: primera etapa." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Siles M" 1 => "Goldaracena M." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Aten Primaria" "fecha" => "2000" "volumen" => "26" "paginaInicial" => "66" "paginaFinal" => "76" ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib33" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Implantación de medicamentos genéricos (EFG) en España y Cataluña: posibilidades de ahorro. Aten Primaria 2000;26:38-51." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Implantación de medicamentos genéricos (EFG) en España y Cataluña: posibilidades de ahorro." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Torralba M" 1 => "Gilabert A" 2 => "Peláez de Loño J" 3 => "Faixedas MT." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "2000" "volumen" => "26" "paginaInicial" => "38" "paginaFinal" => "51" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10916900" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib34" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Utilidad de la prescripción de genéricos en la contención del gasto en prestación farmacéutica. Análisis en la Comunidad Foral de Navarra. Aten Primaria 1996;17:411-4." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Utilidad de la prescripción de genéricos en la contención del gasto en prestación farmacéutica. Análisis en la Comunidad Foral de Navarra." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Ansa I" 1 => "Aguado C" 2 => "Artázcoz M" 3 => "Carnicero J." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1996" "volumen" => "17" "paginaInicial" => "411" "paginaFinal" => "4" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8672647" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib35" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Garantía de calidad en atención primaria: opciones y resultados del programa ibérico. Libro de comunicaciones al X Congreso de la semFYC. Barcelona, 1990." "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Saturno PJ" 1 => "Imperatori B" 2 => "Corbella T." ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib36" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Persistence of improvement in antibiotic prescribing in office practice. J Am Med Assoc 1985;253:1774-6." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Persistence of improvement in antibiotic prescribing in office practice." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Ray WA" 1 => "Schaffner W" 2 => "Tederspiel CF." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Med Assoc" "fecha" => "1985" "volumen" => "253" "paginaInicial" => "1774" "paginaFinal" => "6" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib37" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Promoting rational prescribing: an international perspective. Br J Clin Pharmac 1995;39:1-6." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Promoting rational prescribing: an international perspective." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Hogerzeil HV." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br J Clin Pharmac" "fecha" => "1995" "volumen" => "39" "paginaInicial" => "1" "paginaFinal" => "6" ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib38" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "A study of general practitioners´ reasons for changing their prescribing behaviour. BMJ 1996;312:949-52." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "A study of general practitioners´ reasons for changing their prescribing behaviour." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Amstrong D" 1 => "Reyburn H" 2 => "Jones R." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1996" "volumen" => "312" "paginaInicial" => "949" "paginaFinal" => "52" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8616310" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib39" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Improving drug prescribing in a primary care practice. Medical Care 1984;22:193-201." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Improving drug prescribing in a primary care practice." "idioma" => "ro" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Gelbach SH." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Medical Care" "fecha" => "1984" "volumen" => "22" "paginaInicial" => "193" "paginaFinal" => "201" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6700282" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib40" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Impacto de un proceso de feed-back informativo sobre la prescripción farmacéutica. Aten Primaria 1996;18:386-9." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Impacto de un proceso de feed-back informativo sobre la prescripción farmacéutica." "idioma" => "es" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Pérez MT" 1 => "Crusat D" 2 => "Ibáñez JL" 3 => "Jiménez J." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Aten Primaria" "fecha" => "1996" "volumen" => "18" "paginaInicial" => "386" "paginaFinal" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8998301" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673611617868" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib41" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The effect of computerized feed-back coupled with a newsletter upon outpatient prescribing charges. Med Care 1988;26:88-94." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The effect of computerized feed-back coupled with a newsletter upon outpatient prescribing charges." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Hershey CD" 1 => "Harold I" 2 => "Goldberg M" 3 => "Cohan DI." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Care" "fecha" => "1988" "volumen" => "26" "paginaInicial" => "88" "paginaFinal" => "94" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3336248" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib42" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Randomised controlled trial of effects of feedback on general practitioners´ prescribing in Australia. BMJ 1999;318:507-11." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Randomised controlled trial of effects of feedback on general practitioners´ prescribing in Australia." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "O´Connell DL" 1 => "Henry D" 2 => "Tomlins R." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1999" "volumen" => "318" "paginaInicial" => "507" "paginaFinal" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10024260" "web" => "Medline" ] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib43" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Predictors of physicians prescribing change in an educational experiment to improve medication use. Medical Care 1987;25:210-21." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Predictors of physicians prescribing change in an educational experiment to improve medication use." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Soumerai SB" 1 => "Avorn J." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Medical Care" "fecha" => "1987" "volumen" => "25" "paginaInicial" => "210" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3821226" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/02126567/0000002900000007/v0_201607121052/13031954/v0_201607121052/en/main.assets" "Apartado" => array:4 [ "identificador" => "14695" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Originales" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02126567/0000002900000007/v0_201607121052/13031954/v0_201607121052/en/27v29n07a13031954pdf001.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13031954?idApp=UINPBA00004N" ]
Original language: English
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 6 | 0 | 6 |
2024 October | 33 | 2 | 35 |
2024 September | 39 | 4 | 43 |
2024 August | 28 | 5 | 33 |
2024 July | 31 | 8 | 39 |
2024 June | 47 | 5 | 52 |
2024 May | 24 | 6 | 30 |
2024 April | 35 | 6 | 41 |
2024 March | 63 | 11 | 74 |
2024 February | 69 | 13 | 82 |
2024 January | 77 | 9 | 86 |
2023 December | 65 | 6 | 71 |
2023 November | 65 | 7 | 72 |
2023 October | 95 | 18 | 113 |
2023 September | 63 | 1 | 64 |
2023 August | 70 | 10 | 80 |
2023 July | 48 | 6 | 54 |
2023 June | 59 | 12 | 71 |
2023 May | 70 | 11 | 81 |
2023 April | 52 | 9 | 61 |
2023 March | 49 | 7 | 56 |
2023 February | 47 | 13 | 60 |
2023 January | 66 | 18 | 84 |
2022 December | 45 | 12 | 57 |
2022 November | 82 | 14 | 96 |
2022 October | 51 | 11 | 62 |
2022 September | 60 | 5 | 65 |
2022 August | 47 | 14 | 61 |
2022 July | 44 | 8 | 52 |
2022 June | 46 | 6 | 52 |
2022 May | 46 | 28 | 74 |
2022 April | 53 | 11 | 64 |
2022 March | 63 | 12 | 75 |
2022 February | 36 | 11 | 47 |
2022 January | 41 | 9 | 50 |
2021 December | 103 | 11 | 114 |
2021 November | 71 | 7 | 78 |
2021 October | 86 | 11 | 97 |
2021 September | 43 | 16 | 59 |
2021 August | 47 | 9 | 56 |
2021 July | 26 | 9 | 35 |
2021 June | 45 | 7 | 52 |
2021 May | 40 | 13 | 53 |
2021 April | 102 | 23 | 125 |
2021 March | 57 | 8 | 65 |
2021 February | 25 | 7 | 32 |
2021 January | 53 | 9 | 62 |
2020 December | 46 | 8 | 54 |
2020 November | 44 | 9 | 53 |
2020 October | 56 | 9 | 65 |
2020 September | 47 | 10 | 57 |
2020 August | 61 | 7 | 68 |
2020 July | 38 | 9 | 47 |
2020 June | 75 | 14 | 89 |
2020 May | 40 | 9 | 49 |
2020 April | 34 | 5 | 39 |
2020 March | 62 | 7 | 69 |
2020 February | 73 | 9 | 82 |
2020 January | 46 | 4 | 50 |
2019 December | 56 | 10 | 66 |
2019 November | 40 | 6 | 46 |
2019 October | 57 | 7 | 64 |
2019 September | 67 | 2 | 69 |
2019 August | 35 | 2 | 37 |
2019 July | 45 | 9 | 54 |
2019 June | 78 | 13 | 91 |
2019 May | 165 | 6 | 171 |
2019 April | 85 | 15 | 100 |
2019 March | 28 | 7 | 35 |
2019 February | 25 | 5 | 30 |
2019 January | 21 | 1 | 22 |
2018 December | 26 | 8 | 34 |
2018 November | 48 | 6 | 54 |
2018 October | 28 | 16 | 44 |
2018 September | 19 | 8 | 27 |
2018 August | 8 | 2 | 10 |
2018 July | 8 | 1 | 9 |
2018 June | 14 | 0 | 14 |
2018 May | 14 | 4 | 18 |
2018 April | 5 | 9 | 14 |
2018 March | 9 | 0 | 9 |
2018 February | 8 | 3 | 11 |
2018 January | 11 | 0 | 11 |
2017 December | 12 | 2 | 14 |
2017 November | 14 | 0 | 14 |
2017 October | 14 | 8 | 22 |
2017 September | 14 | 4 | 18 |
2017 August | 15 | 4 | 19 |
2017 July | 10 | 0 | 10 |
2017 June | 29 | 4 | 33 |
2017 May | 24 | 4 | 28 |
2017 April | 12 | 5 | 17 |
2017 March | 16 | 9 | 25 |
2017 February | 25 | 4 | 29 |
2017 January | 19 | 4 | 23 |
2016 December | 27 | 6 | 33 |
2016 November | 25 | 3 | 28 |
2016 October | 40 | 7 | 47 |
2016 September | 29 | 1 | 30 |
2016 August | 23 | 3 | 26 |
2016 July | 18 | 7 | 25 |
2016 June | 22 | 11 | 33 |
2016 May | 13 | 14 | 27 |
2016 April | 12 | 2 | 14 |
2016 March | 13 | 6 | 19 |
2016 February | 13 | 1 | 14 |
2016 January | 13 | 5 | 18 |
2015 December | 17 | 4 | 21 |
2015 November | 15 | 1 | 16 |
2015 October | 28 | 5 | 33 |
2015 September | 26 | 3 | 29 |
2015 August | 4 | 1 | 5 |
2015 July | 19 | 5 | 24 |
2015 June | 2 | 2 | 4 |
2015 May | 9 | 1 | 10 |
2015 April | 20 | 10 | 30 |
2015 March | 17 | 6 | 23 |
2015 February | 11 | 2 | 13 |
2015 January | 25 | 3 | 28 |
2014 December | 19 | 4 | 23 |
2014 November | 21 | 1 | 22 |
2014 October | 26 | 1 | 27 |
2014 September | 25 | 0 | 25 |
2014 August | 27 | 3 | 30 |
2014 July | 28 | 2 | 30 |
2014 June | 34 | 4 | 38 |
2014 May | 17 | 0 | 17 |
2014 April | 17 | 0 | 17 |
2014 March | 20 | 0 | 20 |
2014 February | 19 | 0 | 19 |
2014 January | 12 | 0 | 12 |
2013 December | 8 | 1 | 9 |
2013 November | 14 | 1 | 15 |
2013 October | 18 | 2 | 20 |
2013 September | 11 | 2 | 13 |
2013 August | 17 | 1 | 18 |
2013 July | 9 | 0 | 9 |
2002 April | 692 | 0 | 692 |